Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Détails bibliographiques
Auteur principal:	Das, Reshita
Autres auteurs:	Omer, Humair Bin MD
Format:	Thèse
Langue:	English
Publié:	Brac University 2024
Sujets:	Molecular docking NSCLC 5GPG Structure-based drug design Lung cancer Pharmaceutical chemistry. Biomolecules > Structure. Drugs > Design. Lungs > Cancer.
Accès en ligne:	http://hdl.handle.net/10361/23926

Documents similaires

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

A review on principles of molecular docking and its application in drug discovery
par: Sharif Ezzaz, Ahamed
Publié: (2024)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
par: Araf, Faiaz Fahim
Publié: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
par: Shabnam, Musharrat
Publié: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

Use of combination of satins as antagonists of SPARC in stomach cancer: an in silico study
par: Rashed, Sadman Sakib Bin
Publié: (2019)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

Molecular docking of Fluvastatin and Teneligliptin targeting AT1R in hypertension
par: Jahan, Esrat
Publié: (2020)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
par: Mukti, Roushney Fatima, et autres
Publié: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
par: Tabassum, Azwada
Publié: (2021)

The role of cryo-electron microscopy in anticancer drug discovery and development
par: Alam, Jemima
Publié: (2021)

Oncogenes: new targets in cancer treatment
par: Chowdhury, Waseka Shams
Publié: (2020)

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
par: Hoque, Syeda Mehren
Publié: (2024)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
par: Hasan, Samir, et autres
Publié: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

A computational approach to find alternative drugs for managing depression
par: Mubashira, Musharrat Shaheed
Publié: (2022)

The impact of cell penetrating peptides in prospective cancer therapy: a review
par: Nashrah, Zannatul
Publié: (2023)

A novel vaccine designing approach through analyzing computational tools against pathogenic vibrio cholerae’s outer membrane protein of O1 strain as adjuvant
par: Hossain, Ashraf
Publié: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
par: Rahman, Ahadina
Publié: (2018)

Investigation of cytotoxic and antibacterial activity of methanol extract of callicarpa macrophylla leaves
par: Mona, Rubaiyat Islam
Publié: (2017)